Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cancer Stem Cell Vaccine in Metastatic Lung Adenocarcinoma
NCT02084823Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
Phase 2, randomised trial in lung adenocarcinoma (4 arms), sponsored by Fuda Cancer Hospital. Primary endpoint: Number of participants with adverse events at 3 months. Started Mar 2014; status: completed.
02
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT02084823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084823.